Non-Segmental Vitiligo Research Trial (60 Weeks)

Adults 18-75 years of age with a clinical diagnosis of non-segmental vitiligo (loss of skin pigment), may qualify to participate. Individuals must have a loss of skin pigment on the face and body. History of prior vitiligo treatment with a total duration of at least 3 months, is also required.

Participants will receive investigational oral medication (active study drug) or placebo, during the initial treatment period. In the extension period, all subjects will receive active study drug. Study medication and study-related procedures will be provided at no cost. Reimbursement for study-related expenses will also be provided.

Study participation will last about 60 weeks and involve about 16 visits to the study centre. Four visits will be conducted remotely via a phone or video call, with at-home blood collection occurring by way of home nursing services.

Call the study centre near you, or register now.

Learn more about
Vitiligo
Register Now!

Participating Locations

AR

  • Sorry no locations are available in this country.

AU

  • Sorry no locations are available in this country.

CL

  • Sorry no locations are available in this country.

MX

  • Sorry no locations are available in this country.

US

  • Sorry no locations are available in this country.

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more